European Biotech Acquisition Buy Hold or Sell Recommendation

EBACDelisted Stock  USD 11.19  0.10  0.90%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding European Biotech Acquisition is 'Not Rated'. Macroaxis provides European Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EBAC positions. The advice algorithm takes into account all of European Biotech's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting European Biotech's buy or sell advice are summarized below:
Real Value
9.33
Hype Value
11.19
Market Value
11.19
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell European Biotech Acquisition given historical horizon and risk tolerance towards European Biotech. When Macroaxis issues a 'buy' or 'sell' recommendation for European Biotech Acquisition, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
In addition, we conduct extensive research on individual companies such as European and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards European Biotech Acquisition. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

Execute European Biotech Buy or Sell Advice

The European recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on European Biotech Acquisition. Macroaxis does not own or have any residual interests in European Biotech Acquisition or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute European Biotech's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell European BiotechBuy European Biotech
Not Rated
For the selected time horizon European Biotech Acquisition has a Risk Adjusted Performance of 0.053, Jensen Alpha of 0.2385, Total Risk Alpha of (0.04), Sortino Ratio of 0.047 and Treynor Ratio of (0.24)
Our trade advice tool can cross-verify current analyst consensus on European Biotech Acq and to analyze the company potential to grow in the current economic cycle. To make sure European Biotech is not overpriced, please confirm all European Biotech Acq fundamentals, including its cash flow from operations, market capitalization, and the relationship between the current ratio and earnings per share . Given that European Biotech Acq has a cash per share of 0.02 X, we urge you to verify European Biotech Acquisition market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

European Biotech Trading Alerts and Improvement Suggestions

European Biotech Acq is not yet fully synchronised with the market data
European Biotech Acq has a very high chance of going through financial distress in the upcoming years
European Biotech Acquisition currently holds about 308.1 K in cash with (514.79 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 72.0% of the company shares are held by institutions such as insurance companies

European Biotech Returns Distribution Density

The distribution of European Biotech's historical returns is an attempt to chart the uncertainty of European Biotech's future price movements. The chart of the probability distribution of European Biotech daily returns describes the distribution of returns around its average expected value. We use European Biotech Acquisition price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of European Biotech returns is essential to provide solid investment advice for European Biotech.
Mean Return
0.21
Value At Risk
-3.16
Potential Upside
0.20
Standard Deviation
2.86
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of European Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

European Biotech Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as European . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About European Biotech Buy or Sell Advice

When is the right time to buy or sell European Biotech Acquisition? Buying financial instruments such as European Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having European Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Entertainment Thematic Idea Now

Entertainment
Entertainment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Entertainment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the European Biotech Acq information on this page should be used as a complementary analysis to other European Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in European Stock

If you are still planning to invest in European Biotech Acq check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the European Biotech's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios